Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Inmune Bio ( (INMB) ) has provided an announcement.
INmune Bio Inc. authorized stock options for its non-employee directors and key executives, allowing them to purchase shares at $5.05 under the 2021 Stock Incentive Plan. These options, granted on December 4, 2024, will be fully vested by December 5, 2026, and expire in 2034, providing an opportunity for potential long-term gains as part of their compensation strategy.
For a thorough assessment of INMB stock, go to TipRanks’ Stock Analysis page.
